Calcific Tendonitis Treatment-Barbotage vs. Barbotage with Cortisone Injection: A Randomized Controlled Double-Blind Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Calcific Tendonitis
  • Age: Between 18 - 90 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects who are diagnosed with calcific tendonitis and ruled out other shoulder-related pathologies
    2. Subjects who failed 1st line therapy (physical therapy and cortisone injection)
    3. Subjects with intention to receive barbotage with cortisone as standard of care
    4. Subjects who have 3 or more months of shoulder pain
    5. Subjects with one or more calcifications =5 mm in size on either sonogram or radiograph, located on the supraspinatus tendon
    6. Positive Hawkin’s test or Neer’s sign for impingement

You may not be eligible for this study if the following are true:

    1. Legally incompetent or mentally impaired
    2. Subjects with osteoarthritis of the glenohumeral joint of the affected shoulder
    3. Subjects with previous surgery or barbotage to the affected shoulder
    4. History of prior allergic/hypersensitivity reactions related to the study medication
    5. Subjects with shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy
    6. Subjects who had sub-acromial injection with a corticosteroid or treatment by ESWT during the last 3 months before inclusion
    7. Younger than 18 years of age or older than 90
    8. Any subjects considered a vulnerable subject

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.